GeneNeer develops gene editing tools for crop development. Their product, Superlines, is designed to accelerate new crop development by improving speed, safety, and accuracy. GeneNeer aims to address challenges in cultivating crops amidst climate change while enhancing global food security and sustainability.

GeneNeer

GeneNeer aims to become the world’s leading company for resilient crop seed innovation, with the safest, fastest response to crop loss caused by rapid climate change. Using its breakthrough gene-editing technology, based on Superlines and tissue-specific silencing capabilities, the company will provide eco-friendly plant protection against pests, viruses and other biotic stresses that threaten global food security.


JANSZKY GmbH

2b AHEAD Ventures Fund

Kinneret Shefer meets Ciska van den Berg in Amsterdam to welcome her to GeneNeer’s Board of Directors, 
 after her contribution to the company as a StartLife Mentor. In her day job, Ciska is Project Lead Sustainable Innovation at Rabobank in Utrecht, NL, specializing in initiating, developing and accelerating new business propositions. 
We hope Ciska will feel right at home advising us as we progress in developing our crop enhancement and breeding technology.
#femaleleaders #agritech #investors

Congratulations to Oded Shoseyov, GeneNeer’s Chairman, for being awarded The 2024 Landau Prize for Arts and Sciences in Biotechnology for outstanding advancements. His research proves the ability to discover unique properties of biomaterials and functional structures found in nature and to manufacture them through biotechnological processes – contributing to the sustainability of diverse industries, ranging from agriculture to space electronics. We are lucky to have you on our team and greatly admire your continued success and contribution to the sciences.

#Sustainability #Biotechnology #Agriculture

This morning we saw pitches from several companies who are advancing crop protection, the future of sustainable practices, and plant nutrition through cutting-edge biology and next-generation delivery mechanisms.

Presenters included: 

Esteban Hernando, CSO, Cálice
Masaki Niwa, CEO, GRA&GREEN Inc.
Joaquín Fisch Fisch, Co-Founder & CEO, NAT4Bio
PJ Steiner, Co-Founder & CEO, Ohmic Biosciences (YC S23)
Rory Hornby, CSO & Co-Founder, Alora
Rafael Simon, CEO, SILVEC
Pam Marrone, Executive Chair & Co-Founder, Invasive Species Corporation & Invasive Species Research Institute
Kinneret Shefer, CEO & Co-Founder, GeneNeer

#WorldAgriTech #AgDay24

Metric
Company Name	GeneNeer
Symbol
MSH ID	COM:GENENEER
Market	PRIVATE
Sector	Technology
Industry	Agricultural Biotechnology
Country	US
Stage
Employee Count	8
Website	geneneer.com
LinkedIn	geneneer
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:GENENEER

GeneNeer

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue